Ian F. Tannock
Ian F. Tannock, CM, MD, PhD, DSc

Emeritus professor of medical oncology, Princess Margaret Cancer Centre; Director, Optimal Cancer Care Alliance

Latest Stories

Guest Editorial
On May 28, 2021, the FDA granted an accelerated approval for sotorasib (which had previously received Breakthrough designation) for previously treated KRAS G12C non-small cell lung cancer (NSCLC) at a dose of 960 mg daily.
Guest Editorial
“We are going to start making this a requirement”, stated Richard Pazdur, MD during STAT’s ASCO Recap on June 9, 2021.